Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Palliative care & heart failure | IVL for mitral valve disease | New coronary sinus reducer data | $32M for LAAO tech
Thursday, August 14, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Palliative care plays an essential role in heart failure care

New HFSA recommendations highlight the importance of integrating palliative care into the day-to-day care of heart failure patients.

READ MORE >
Senior Patient
Share on Twitter Share on Facebook Share on Linkedin

Palliative care plays an essential role in heart failure care

Share on Twitter Share on Facebook Share on Linkedin
Senior Patient
New HFSA recommendations highlight the importance of integrating palliative care into the day-to-day care of heart failure patients.
READ MORE >

Can IVL help cardiologists treat mitral valve disease?

Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification. 

READ MORE >
Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).
Share on Twitter Share on Facebook Share on Linkedin

Can IVL help cardiologists treat mitral valve disease?

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).
Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification. 
READ MORE >

Coronary sinus reducer linked to improvements in patients with refractory angina—but questions remain

Treatment with the device is consistently safe, but researchers still think more data is required before reaching any conclusions about its efficacy. 

READ MORE >
coronary sinus reducer shockwave medical
Share on Twitter Share on Facebook Share on Linkedin

Coronary sinus reducer linked to improvements in patients with refractory angina—but questions remain

Share on Twitter Share on Facebook Share on Linkedin
coronary sinus reducer shockwave medical
Treatment with the device is consistently safe, but researchers still think more data is required before reaching any conclusions about its efficacy. 
READ MORE >

Medtech company raises $32M for foam-based LAAO device

New Hampshire-based Conformal Medical plans on using the funds to enroll more patients into an ongoing clinical trial. 

READ MORE >
Conformal Medical CLAAS
Share on Twitter Share on Facebook Share on Linkedin

Medtech company raises $32M for foam-based LAAO device

Share on Twitter Share on Facebook Share on Linkedin
Conformal Medical CLAAS
New Hampshire-based Conformal Medical plans on using the funds to enroll more patients into an ongoing clinical trial. 
READ MORE >

Featured Articles

Pericarditis: New guidance takes on the diagnosis and management of a challenging heart condition

Pericarditis, inflammation of the pericardium, accounts for approximately 5% of all emergency department evaluations for chest pain. These new recommendations are designed to help guide clinicians through the ins and outs of patient care. 

READ MORE >
Pericardial Effusion Sizing Evaluation by Echocardiography. Representative (A) small, (B) moderate, and (C) large PEffs (∗). Representative (D) simple PEff with fibrin strands, (E) exudative PEff, and (F) malignant PEff (∗) caused by pericardial mesothelioma. Adapted with permission from Klein et al. Images and caption courtesy of the American College of Cardiology and JACC.pericarditis cardiac imaging
Share on Twitter Share on Facebook Share on Linkedin

Pericarditis: New guidance takes on the diagnosis and management of a challenging heart condition

Share on Twitter Share on Facebook Share on Linkedin
Pericardial Effusion Sizing Evaluation by Echocardiography. Representative (A) small, (B) moderate, and (C) large PEffs (∗). Representative (D) simple PEff with fibrin strands, (E) exudative PEff, and (F) malignant PEff (∗) caused by pericardial mesothelioma. Adapted with permission from Klein et al. Images and caption courtesy of the American College of Cardiology and JACC.pericarditis cardiac imaging
Pericarditis, inflammation of the pericardium, accounts for approximately 5% of all emergency department evaluations for chest pain. These new recommendations are designed to help guide clinicians through the ins and outs of patient care. 
READ MORE >

AI now embedded in nearly every cardiovascular IT system

Artificial intelligence's role in day-to-day patient care continues to grow. What should health systems and cardiology departments be thinking about as they shop for new technologies?

READ MORE >
Amy Thompson from Signify Research explains integration of AI into CVIS systems
Share on Twitter Share on Facebook Share on Linkedin

AI now embedded in nearly every cardiovascular IT system

Share on Twitter Share on Facebook Share on Linkedin
Amy Thompson from Signify Research explains integration of AI into CVIS systems
Artificial intelligence's role in day-to-day patient care continues to grow. What should health systems and cardiology departments be thinking about as they shop for new technologies?
READ MORE >

High cost of cardiac amyloidosis drugs may limit access for low-income patients

"We cannot accept a system where only those with means can benefit from life-changing drugs. We are a wealthy nation that spends trillions on healthcare. We must ensure that income and wealth do not determine access," explained JACC Editor-in-Chief Harlan M. Krumholz, MD.

READ MORE >
Cardiac amyloidosis ATTR-CM drug promotion at the 2024 American Heart Association meeting.
Share on Twitter Share on Facebook Share on Linkedin

High cost of cardiac amyloidosis drugs may limit access for low-income patients

Share on Twitter Share on Facebook Share on Linkedin
Cardiac amyloidosis ATTR-CM drug promotion at the 2024 American Heart Association meeting.
"We cannot accept a system where only those with means can benefit from life-changing drugs. We are a wealthy nation that spends trillions on healthcare. We must ensure that income and wealth do not determine access," explained JACC Editor-in-Chief Harlan M. Krumholz, MD.
READ MORE >

Heartflow raises $364M with IPO, rings Nasdaq opening bell

Heartflow has officially gone public after selling more than 19 million shares of common stock during an upsized IPO. The California medtech company, known for its AI-powered CCTA evaluations, is now being traded on Nasdaq under the symbol HTFL.

READ MORE >
Heartflow president and CEO John Farquhar celebrate the company's IPO by ringing Nasdaq's the ceremonial opening bell.
Share on Twitter Share on Facebook Share on Linkedin

Heartflow raises $364M with IPO, rings Nasdaq opening bell

Share on Twitter Share on Facebook Share on Linkedin
Heartflow president and CEO John Farquhar celebrate the company's IPO by ringing Nasdaq's the ceremonial opening bell.
Heartflow has officially gone public after selling more than 19 million shares of common stock during an upsized IPO. The California medtech company, known for its AI-powered CCTA evaluations, is now being traded on Nasdaq under the symbol HTFL.
READ MORE >

In Case You Missed It

FDA clears wearable heart device that captures multiple signals at once

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.

READ MORE >
Cardiosense CardioTag
Share on Twitter Share on Facebook Share on Linkedin

FDA clears wearable heart device that captures multiple signals at once

Share on Twitter Share on Facebook Share on Linkedin
Cardiosense CardioTag
The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.
READ MORE >

Successful outreach program brings heart screenings to underserved communities

Former ACC president Kim Allan Williams Sr., MD, shared his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said. 

READ MORE >
Video with former ACC president Kim Williams, MD, discusses a heart screening outreach program he created in low-income Louisville neighborhoods.
Share on Twitter Share on Facebook Share on Linkedin

Successful outreach program brings heart screenings to underserved communities

Share on Twitter Share on Facebook Share on Linkedin
Video with former ACC president Kim Williams, MD, discusses a heart screening outreach program he created in low-income Louisville neighborhoods.
Former ACC president Kim Allan Williams Sr., MD, shared his experience bringing helpful heart screenings to low-income neighborhoods. "You've got to be willing to go out and find where the patients are," he said. 
READ MORE >

Smoking cannabis may not impact heart health of older CAD patients

Researchers explored data from thousands of U.S. veterans with coronary artery disease, sharing their findings in Circulation.

READ MORE >
cannabis weed marijuana heart health doctor cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Smoking cannabis may not impact heart health of older CAD patients

Share on Twitter Share on Facebook Share on Linkedin
cannabis weed marijuana heart health doctor cardiologist
Researchers explored data from thousands of U.S. veterans with coronary artery disease, sharing their findings in Circulation.
READ MORE >

In Other News

Could ChatGPT be up to the task of monitoring AI drift?

Artificial intelligence tools in radiology require constant monitoring to ensure model performance remains consistent.

READ MORE >
radiology structured reporting data mining
Share on Twitter Share on Facebook Share on Linkedin

Could ChatGPT be up to the task of monitoring AI drift?

Share on Twitter Share on Facebook Share on Linkedin
radiology structured reporting data mining
Artificial intelligence tools in radiology require constant monitoring to ensure model performance remains consistent.
READ MORE >

ACR forms task force to explore corporatization and consolidation in radiology

“We need a common understanding of what is happening out there. As it stands now, we don’t have fundamental terms defined that are necessary to make informed plans and decisions," one rad says. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

ACR forms task force to explore corporatization and consolidation in radiology

Share on Twitter Share on Facebook Share on Linkedin
“We need a common understanding of what is happening out there. As it stands now, we don’t have fundamental terms defined that are necessary to make informed plans and decisions," one rad says. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI
Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software
Private equity unlikely to dominate cardiology | Cardiology opposes Medicare AI prior authorization | New AATS leaders
The real impact of RVU cuts in electrophysiology | TAVR changes on the way | Cardiology groups celebrate bill | BP drug recalled

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup